deltatrials
Unknown OBSERVATIONAL NCT03925233

Breast Cancer Treatment Based on Organ-like Culture

Sensitivity Detection and Drug Resistance Mechanism of Breast Cancer Therapeutic Drugs Based on Organ-like Culture

Sponsor: Xijing Hospital

Conditions Breast Cancer Organoids
Interventions Aidi Injection Anastrozole Apatinib mesylate Bevacizumab Capecitabine Carboplatin Cisplatin Cyclophosphamide Doxorubicin Hydrochloride Ear particles Epirubicin hydrochloride Eribulin mesylate Exemestane Fluorouracil Fulvestrant Gemcitabine Ixabepilone Letrozole Methotrexate Olaparib Paclitaxel Pattozumab Pirarubicin hydrochloride Pyrrolidine Recombinant Human Endostatin Tamoxifen citrate Toremifene citrate Trastuzumab Vinorelbine tartrate
Updated 5 times since 2019 Last updated: Apr 23, 2019 Started: Jan 2, 2019 Primary completion: Dec 15, 2021 Completion: Dec 15, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer Organoids and is currently ongoing. Xijing Hospital leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2019 – ~Jan 2021 · 20 months · monthly snapshotEnrolling By Invitation~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotEnrolling By Invitation~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Jan 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: Enrolling By Invitation → Unknown Status

  4. Jan 2021 — Jan 2022 [monthly]

    Enrolling By Invitation

  5. May 2019 — Jan 2021 [monthly]

    Enrolling By Invitation

    First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Xijing Hospital
Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations